One commonly cited formulation lists 50 mg GHK-Cu, 10 mg KPV, 10 mg BPC-157, and 10 mg TB-500 per vial , for a total of 80 mg , with GHK-Cu accounting for 62.5% of the blend and each of the other three peptides contributing 12.5% by mass, according to Protide Healths KLOW peptide guide
Freshly activated, its a super lightweight and watery face serum, making it easily layered into your skincare routine before or after other serums
It does not irritate or dry out the skin
In explaining the addition, the United States Anti-Doping Agency (USADA) noted that BPC-157 is not currently approved for use as a human drug, but instead has been investigated for inflammatory bowel disease and soft tissue healing, although there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without any published conclusions. But banning a substance only makes it more attractive to a certain kind of guy
Primary peptide: KPV at 300 to 500 mcg subcutaneously daily (NF-kB suppression in airway epithelium) Support peptide: Ta1 at 1.6 mg subcutaneously twice weekly (immune rebalancing) Duration: 8 to 12 weeks minimum, with reassessment Important note: Peptide protocols for asthma should complement, not replace, prescribed controller medications